Literature DB >> 24003282

Generalized dowling-degos disease: case reports.

Jade Wititsuwannakul1, Nopadon Noppakun.   

Abstract

Dowling-Degos disease (DDD) is a rare autosomal dominant trait characterized by numerous, symmetrical, progressive and pigmented macules over the axillae, groins, face, neck, arms and trunk as well as scattered comedo-like lesions (dark dot, follicles) and pitted acneiform scars. Histopathology is diagnostic testing using a distinctive form of acanthosis, characterized by an irregular elongation of thin branching rete ridges, with a concentration of melanin at the tips. We report cases of generalized DDD in a single family with autosomal dominant penetrance. DDD can be presented in a generalized form with hypopigmented lesions instead of reticulate hyperpigmentation confined to the flexor areas. This form can be differentiated from DUH by histopathology.

Entities:  

Keywords:  Dowling-Degos disease; Pigmentary disorder; Reticulate

Year:  2013        PMID: 24003282      PMCID: PMC3756204          DOI: 10.5021/ad.2013.25.3.360

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  19 in total

1.  Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities.

Authors:  J M Bonifas; A L Rothman; E H Epstein
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

Review 2.  Dyschromatosis symmetrica hereditaria (reticulate acropigmentation of Dohi): report of a Japanese family with the condition and a literature review of 185 cases.

Authors:  M Oyama; H Shimizu; Y Ohata; S Tajima; T Nishikawa
Journal:  Br J Dermatol       Date:  1999-03       Impact factor: 9.302

3.  Dowling-Degos disease (reticulate pigmented anomaly of the flexures): a clinical and histopathologic study of 6 cases.

Authors:  Y C Kim; M D Davis; C F Schanbacher; W P Su
Journal:  J Am Acad Dermatol       Date:  1999-03       Impact factor: 11.527

4.  Dowling-Degos disease with dyschromatosis universalis hereditaria-like pigmentation in a family.

Authors:  K Sandhu; A Saraswat; A J Kanwar
Journal:  J Eur Acad Dermatol Venereol       Date:  2004-11       Impact factor: 6.166

5.  Overlap of reticulate acropigmentation of Kitamura, acropigmentation of Dohi and Dowling-Degos disease in four generations.

Authors:  G P Thami; R Jaswal; A J Kanwar; B D Radotra; I P Singh
Journal:  Dermatology       Date:  1998       Impact factor: 5.366

6.  Regional assignment of the human keratin 5 (KRT5) gene to chromosome 12q near D12S14 by PCR analysis of somatic cell hybrids and multicolor in situ hybridization.

Authors:  J M Bonifas; J W Bare; E D Lynch; R V Lebo; E H Epstein
Journal:  Genomics       Date:  1992-06       Impact factor: 5.736

7.  Is Dowling-Degos disease the same disease as Kitamura's reticulate acropigmentation?

Authors:  F Crovato; G Desirello; A Rebora
Journal:  Br J Dermatol       Date:  1983-07       Impact factor: 9.302

8.  Dowling-Degos disease and Kitamura's reticulate acropigmentation: support for the concept of a single disease.

Authors:  N H Cox; E Long
Journal:  Br J Dermatol       Date:  1991-08       Impact factor: 9.302

9.  Loss-of-function mutations in the keratin 5 gene lead to Dowling-Degos disease.

Authors:  Regina C Betz; Laura Planko; Sibylle Eigelshoven; Sandra Hanneken; Sandra M Pasternack; Heinrich Bussow; Kris Van Den Bogaert; Joerg Wenzel; Markus Braun-Falco; Arno Rutten; Michael A Rogers; Thomas Ruzicka; Markus M Nöthen; Thomas M Magin; Roland Kruse
Journal:  Am J Hum Genet       Date:  2006-01-19       Impact factor: 11.025

10.  Dowling-Degos disease (reticulate pigmented anomaly of the flexures) is an autosomal dominant condition.

Authors:  F Crovato; G Nazzari; A Rebora
Journal:  Br J Dermatol       Date:  1983-04       Impact factor: 9.302

View more
  1 in total

1.  Follicular Dowling-Degos Disease Camouflaged as Comedones: A Case Report and Literature Review.

Authors:  Arundhathi S; Poongodi Rajagopal; Hima Gopinath; Jami Rupa Ramani
Journal:  Cureus       Date:  2022-06-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.